246 related articles for article (PubMed ID: 18245476)
1. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.
Contreras CM; Gurumurthy S; Haynie JM; Shirley LJ; Akbay EA; Wingo SN; Schorge JO; Broaddus RR; Wong KK; Bardeesy N; Castrillon DH
Cancer Res; 2008 Feb; 68(3):759-66. PubMed ID: 18245476
[TBL] [Abstract][Full Text] [Related]
2. LKB1 mutation in large cell carcinoma of the lung.
Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
[TBL] [Abstract][Full Text] [Related]
3. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.
Bardeesy N; Sinha M; Hezel AF; Signoretti S; Hathaway NA; Sharpless NE; Loda M; Carrasco DR; DePinho RA
Nature; 2002 Sep; 419(6903):162-7. PubMed ID: 12226664
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
[TBL] [Abstract][Full Text] [Related]
6. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.
Fernandez P; Carretero J; Medina PP; Jimenez AI; Rodriguez-Perales S; Paz MF; Cigudosa JC; Esteller M; Lombardia L; Morente M; Sanchez-Verde L; Sotelo T; Sanchez-Cespedes M
Oncogene; 2004 Jun; 23(29):5084-91. PubMed ID: 15077168
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.
Miyoshi H; Nakau M; Ishikawa TO; Seldin MF; Oshima M; Taketo MM
Cancer Res; 2002 Apr; 62(8):2261-6. PubMed ID: 11956081
[TBL] [Abstract][Full Text] [Related]
8. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.
Peña CG; Nakada Y; Saatcioglu HD; Aloisio GM; Cuevas I; Zhang S; Miller DS; Lea JS; Wong KK; DeBerardinis RJ; Amelio AL; Brekken RA; Castrillon DH
J Clin Invest; 2015 Nov; 125(11):4063-76. PubMed ID: 26413869
[TBL] [Abstract][Full Text] [Related]
9. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours.
Wang ZJ; Churchman M; Campbell IG; Xu WH; Yan ZY; McCluggage WG; Foulkes WD; Tomlinson IP
Br J Cancer; 1999 Apr; 80(1-2):70-2. PubMed ID: 10389980
[TBL] [Abstract][Full Text] [Related]
10. LKB1; linking cell structure and tumor suppression.
Hezel AF; Bardeesy N
Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
[TBL] [Abstract][Full Text] [Related]
11. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
Scott KD; Nath-Sain S; Agnew MD; Marignani PA
Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
[TBL] [Abstract][Full Text] [Related]
12. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.
Wei C; Amos CI; Stephens LC; Campos I; Deng JM; Behringer RR; Rashid A; Frazier ML
Cancer Res; 2005 Dec; 65(24):11297-303. PubMed ID: 16357136
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of tumor suppression by LKB1.
Vaahtomeri K; Mäkelä TP
FEBS Lett; 2011 Apr; 585(7):944-51. PubMed ID: 21192934
[TBL] [Abstract][Full Text] [Related]
15. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.
Carretero J; Medina PP; Pio R; Montuenga LM; Sanchez-Cespedes M
Oncogene; 2004 May; 23(22):4037-40. PubMed ID: 15021901
[TBL] [Abstract][Full Text] [Related]
16. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.
Strazisar M; Mlakar V; Rott T; Glavac D
Cancer Invest; 2009 May; 27(4):407-16. PubMed ID: 19229701
[TBL] [Abstract][Full Text] [Related]
17. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.
Jansen M; Ten Klooster JP; Offerhaus GJ; Clevers H
Physiol Rev; 2009 Jul; 89(3):777-98. PubMed ID: 19584313
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer.
Lian Z; De Luca P; Di Cristofano A
J Cell Physiol; 2006 Aug; 208(2):255-66. PubMed ID: 16688764
[TBL] [Abstract][Full Text] [Related]
19. Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy.
Contreras CM; Akbay EA; Gallardo TD; Haynie JM; Sharma S; Tagao O; Bardeesy N; Takahashi M; Settleman J; Wong KK; Castrillon DH
Dis Model Mech; 2010; 3(3-4):181-93. PubMed ID: 20142330
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice.
Nakau M; Miyoshi H; Seldin MF; Imamura M; Oshima M; Taketo MM
Cancer Res; 2002 Aug; 62(16):4549-53. PubMed ID: 12183403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
